Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates

Rutter JM. Pasteurella multocida. In: Adlam C, editor. Pasteurella and pasteurellosis. San Diego: Academic Press; 1989. p. 37–75.

Shah, 2001, Safety and efficacy of an oil-adjuvant vaccine against haemorrhagic septicaemia in buffalo calves: cross-protection between the serotypes B:2,5 and E:2,5, Vet Rec, 149, 583, 10.1136/vr.149.19.583

Whiteley, 1992, Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis, J Vet Intern Med, 6, 11, 10.1111/j.1939-1676.1992.tb00980.x

Lu, 1991, The outer membrane of Pasteurella multocida 3A protects rabbits against a homologous challenge, Infect Immun, 59, 4517, 10.1128/IAI.59.12.4517-4523.1991

Okerman, 1980, Immunity induced in mice by Pasteurella multocida isolated from rabbits, Zentralbl Veterinärmed, 27B, 759, 10.1111/j.1439-0450.1980.tb02030.x

Kasten, 1995, P. multocida produces a protein with homology to the P6 outer membrane protein of Haemophilus influenzae, Infect Immun, 63, 989, 10.1128/IAI.63.3.989-993.1995

Ferguson, 1993, Antigenic structure of poliovirus in inactivated vaccines, J Gen Virol, 74, 685, 10.1099/0022-1317-74-4-685

Melamed, 1991, A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli, Avian Dis, 35, 17, 10.2307/1591289

Nencioni, 1991, Characterisation of genetically inactivated pertussis toxin mutants: Candidates for a new vaccine against whooping caught, Infect Immun, 59, 625, 10.1128/IAI.59.2.625-630.1991

Szostak, 1996, Bacterial ghosts: non-living candidate vaccines, J Biotechnol, 44, 161, 10.1016/0168-1656(95)00123-9

Witte, 1990, Endogenous transmembrane tunnel formation mediated by φX174 lysis protein E, J Bacteriol, 172, 4109, 10.1128/jb.172.7.4109-4114.1990

Witte, 1992, Dynamics of PhiX174 protein E-mediated lysis of E. coli, Arch Microbiol, 157, 381, 10.1007/BF00248685

Eko, 1994, Production of Vibrio cholera-ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development, Vaccine, 12, 1231, 10.1016/0264-410X(94)90249-6

Katinger, 1999, Pigs aerogenously immunized with genetically inactivated (ghosts) of irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses, J Biotech, 72, 247

Panthel, 2002, Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates, Infect Immun, 71, 109, 10.1128/IAI.71.1.109-116.2003

Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.

Witte, 1989, Biochemical characterization of PhiX174 protein E mediated lysis of Escherichia coli, Eur J Biochem, 180, 393, 10.1111/j.1432-1033.1989.tb14661.x

Homchampa, 1997, Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida, Vaccine, 15, 203, 10.1016/S0264-410X(96)00139-9

Marchart, 2003, Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts, Vaccine, 21, 1415, 10.1016/S0264-410X(02)00635-7

Stoscheck, 2001, A general reference on protein quantitation, Methods Enzymol, 182, 50, 10.1016/0076-6879(90)82008-P

Witte, 1998, Characterisation of Escherichia coli lysis using a family of chimeric E–L genes, FEMS Microbiol Lett, 164, 159, 10.1111/j.1574-6968.1998.tb13081.x

Holt, 1990, Immunisation of pigs with killed cultures of Streptococcus suis type 2, Res Vet Sci, 48, 23, 10.1016/S0034-5288(18)31503-0

Eko, 2000, Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili, J Biotechnol, 83, 115, 10.1016/S0168-1656(00)00315-1

Huter, 2000, Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine, J Biotechnol, 83, 161, 10.1016/S0168-1656(00)00310-2

Hensel, 2000, Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state, Vaccine, 18, 2945, 10.1016/S0264-410X(00)00107-9

Witte, 1998, Effect of PhiX174 E-mediated lysis on murein composition of Escherichia coli, FEMS Microbiol Lett, 164, 149